DUBLIN–(BUSINESS WIRE)–The “Nucleic
Acid Isolation and Purification Market – Growth, Trends, and Forecast
(2019 – 2024)” report has been added to ResearchAndMarkets.com’s
offering.
The growth of the nucleic acid isolation and purification market is due
to the rapid technological advancements, wide-range applications of
nucleic acid testing in diagnostics, and rise in the R&D funding in
biotechnology and healthcare.
-
Nucleic acid has many diagnostic applications in tests of many
diseases, such as STDs, congenital anomalies, cancer, etc.
-
According to the US Department of Health & Human Services, there were
approximately 36.7 million people worldwide living with HIV/AIDS as of
2016. Of these, 2.1 million were children (< 15 years old). The WHO
stated that more than 1 million sexually transmitted infections are
acquired every day worldwide and 500 million people are estimated to
have genital infection with herpes simplex virus (HSV), along with 290
million women who have a human papillomavirus (HPV) infection.
Therefore, all STDs can be diagnosed through nucleic acid isolation
and identification procedures, and this signifies that the market
studied is expected to increase globally.
-
The current market is also growing, due to rapid technological
advancements, like polymerase chain reaction (the original nucleic
acid amplification technique), which transformed the approach of the
clinical microbiologists in viewing and using nucleic acid techniques
in clinical settings.
Scope of the Report
As per the scope of the report, nucleic acid isolation and purification
is a procedure in molecular biology techniques, such as cloning,
sequencing, polymerase chain reaction, and other techniques. These
techniques have various applications in the field of genetic
engineering, life science research, forensics, and molecular
diagnostics. The nucleic acid isolation helps in the processing of more
sample in less time, minimizes nucleic acid loss degradation, and
increases laboratory efficiency and effectiveness. It also helps in
purification of nucleic acid.
Key Market Trends
The Equipment Segment is the Fastest Growing Segment and is Expected to
Continue to Grow in the Forecast Period
The equipment segment of the market studied is growing at a good pace.
There are significant advancements found in the field of molecular
diagnostics that have facilitated rapid and continued advancements in
nucleic acid isolation and purification technologies, driven by the new
knowledge provided by the mapping of genetic risk factors behind many
diseases, where lifestyle has an important role to play. In addition,
the growth in laboratory automation and decreasing changeability may
lead to the growth of the equipment segment of the market studied.
US Nucleic Acid Isolation and Purification Market is the Largest in
North America and is Expected to Follow the Same Trend Over the Forecast
Period
The US Nucleic Acid Isolation and Purification Market are the largest in
North America that is mainly due to the very high use of downstream
processes in the country. The growth of the market is also attributed
due to the rapid technological advances, wide-range applications of
nucleic acid testing in diagnostics boosting the market, rise in the R&D
funding in biotechnology and healthcare.
Competitive Landscape
Some of the recent market trends in the global nucleic acid isolation
and purification market are new product development, mergers and
acquisition, and partnerships. Agilent Technologies, Bio-Rad
Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, GE
Healthcare, Promega Corporation, Qiagen NV, and Thermo Fisher Scientific
Inc. are some of the major players in the nucleic acid isolation and
purification market.
Key Topics Covered:
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2
Market Drivers
4.2.1 Rapid Technological Advancements Boosting the
Market Growth
4.2.2 Wide-range Applications of Nucleic Acid Testing
in Diagnostics Boosting the Market
4.2.3 Rise in the R&D Funding in
Biotechnology and Healthcare
4.3 Market Restraints
4.3.1 Low
Penetration in the Emerging Markets
4.3.2 Increasing Cost of
Automated Instruments
4.4 Porter’s Five Forces Analysis
5 MARKET SEGMENTATION
5.1 By Technology
5.1.1
Column-based Purification
5.1.2 Magnetic Bead-based Purification
5.1.3
Reagent-based Purification
5.2 By Product
5.2.1 Kits and
Reagents
5.2.2 Equipment
5.2.3 Other Products
5.3 By
Application
5.3.1 Total RNA Isolation and Purification
5.3.2
mRNA Isolation and Purification
5.3.3 microRNA Isolation and
Purification
5.3.4 Plasmid DNA Isolation and Purification
5.3.5
Genomic DNA Isolation and Purification
5.3.6 Blood DNA Isolation
and Purification
5.3.7 PCR Clean-up
5.3.8 Other Nucleic Acid
Isolation and Purification Applications
5.4 By End User
5.4.1
Hospitals
5.4.2 Academia
5.4.3 Pharmaceutical/Biotechnology
Industry
5.4.4 CRO
5.5 Geography
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1
Agilent Technologies
6.1.2 Bio-Rad Laboratories Inc.
6.1.3
BioTek Instruments Inc.
6.1.4 BioVision Inc.
6.1.5 Danaher
Corporation
6.1.6 F. Hoffmann-La Roche Ltd
6.1.7 GE Healthcare
6.1.8
Merck KGaA (Sigma-Aldrich Corporation)
6.1.9 Promega Corporation
6.1.10
Qiagen NV
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/rbp2pj
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Biotechnology